Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
54.34 USD | -0.59% | +5.91% | +11.02% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.02% | 507M | |
+39.65% | 50.93B | |
-0.19% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.95% | 26.02B | |
-22.34% | 18.9B | |
+9.07% | 13.21B | |
+24.58% | 12.17B | |
+29.10% | 12.16B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- HC Wainwright Adjusts Korro Bio's Price Target to $115 From $100, Buy Rating Kept